Richard F. Pops

Insider Reports History

Entity
Individual
Location
10555 Science Center Dr, San Diego, CA
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard F. Pops:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. Director and CEO, Alkermes plc, Director Ordinary Shares 1.18M $31.6M $26.77 Feb 8, 2024 Direct
Alkermes plc. Director and CEO, Alkermes plc, Director Employee Stock Option (Right to Buy) 274K $7.36M $26.82 Feb 26, 2024 Direct
NEUROCRINE BIOSCIENCES INC Director Common Stock 31.6K $4.48M $141.84 May 17, 2024 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 2.87K $407K $141.90 May 22, 2024 Direct
NEUROCRINE BIOSCIENCES INC Director Non-Qualified Stock Option 0 $0 $42.76 Mar 13, 2024 Direct

Insider Reports Filed by Richard F. Pops

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBIX NEUROCRINE BIOSCIENCES INC May 22, 2024 1 $0 4 May 23, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2024 3 -$298K 4 May 21, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC Mar 13, 2024 3 -$3.26M 4 Mar 15, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC Mar 8, 2024 6 -$252K 4 Mar 12, 2024 Director
ALKS Alkermes plc. Feb 26, 2024 12 $2.18M 4 Feb 27, 2024 Director and CEO, Alkermes plc, Director
NBIX NEUROCRINE BIOSCIENCES INC Feb 20, 2024 3 -$1.99M 4 Feb 22, 2024 Director
ALKS Alkermes plc. Feb 8, 2024 2 -$2.46M 4 Feb 12, 2024 Director and CEO, Alkermes plc, Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2023 1 $0 4 May 19, 2023 Director
ALKS Alkermes plc. Feb 23, 2023 1 $0 4 Feb 24, 2023 Director and CEO, Alkermes plc, Director
ALKS Alkermes plc. Feb 20, 2023 5 -$1.89M 4 Feb 22, 2023 Director and CEO, Alkermes plc, Director
NBIX NEUROCRINE BIOSCIENCES INC Jan 3, 2023 3 -$1.79M 4 Jan 5, 2023 Director
NBIX NEUROCRINE BIOSCIENCES INC May 18, 2022 1 $0 4 May 20, 2022 Director
NBIX NEUROCRINE BIOSCIENCES INC May 9, 2022 6 -$1.14M 4 May 11, 2022 Director
ALKS Alkermes plc. May 5, 2022 7 -$2.27M 4 May 6, 2022 Director and CEO, Alkermes plc, Director
ALKS Alkermes plc. Feb 18, 2022 4 -$361K 4 Feb 23, 2022 Director and CEO, Alkermes plc, Director
ALKS Alkermes plc. Feb 16, 2022 3 -$215K 4 Feb 17, 2022 Director and CEO, Alkermes plc, Director
ALKS Alkermes plc. Sep 14, 2021 2 -$1.11M 4 Sep 16, 2021 Director and CEO, Alkermes plc, Director
NBIX NEUROCRINE BIOSCIENCES INC May 19, 2021 1 $0 4 May 20, 2021 Director
ALKS Alkermes plc. May 18, 2021 3 -$570K 4 May 19, 2021 Director and CEO, Alkermes plc, Director
ALKS Alkermes plc. May 11, 2021 4 -$598K 4 May 12, 2021 Director and CEO, Alkermes plc, Director
ALKS Alkermes plc. May 6, 2021 3 -$369K 4 May 7, 2021 Director and CEO, Alkermes plc, Director